Abstract
Background: Sero-surveillance of Hepatitis B virus infection in the Jammu province of J and K, India.
Objectives: The study was envisaged with the objective to (1) Study the Hepatitis B burden in the Jammu province (2) To further formulate the regional management policy, study the Genotypes and conduct Phylogenetic analysis based on this study.
Methods: Referred patient’s blood specimens were collected for HBsAg ELISA and tested. The test results were shared with both patients and the clinicians.
Results: The prospective study was conducted from January 2014 to December 2016 wherein a total of 27,703 ELISA tests were performed and 678 patients were positive (2.44%). Male (64.60%) preponderance was observed over females (35.39%) with an overall positivity of 1.58% and 0.86% respectively. Highest prevalence of 54.71% was observed in the age group of 41-60 years followed by a prevalence of 29.20% in 19 to 40 years, 14.45% in 61-80 and 1.44% in the age group above 80. Of the 27,703 samples screened 449 (1.62%) were from the HIV-ART clinic and 7(1.55%) were found to be co-infected.
Conclusion: A seroprevalence of 2.44% was reported with male predominance (58.35%) with the maximum number of affected population being in the age group of 41-60 years (54.71%). The co prevalence of HBsAg and HIV was found to be 1.55%.
Keywords: Hepatitis B virus, HBsAg ELISA, seroprevalence, preponderance, co- infection.
References
- Global burden of Disease 2016: The Lancet: September 16, 2017
- Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M. Etiology of liver cirrihosis in Japan a Nationwide survey. J Gastroenterol. 2010; 45: 86-4.
- Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ, Goldberg D. Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med. 2011;61:531–540.
- Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatol. 2006; 43:173–81.
- Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok ASF. Management of hepatitis B: summary of a clinical research workshop. Hepato.l 2007; 45:1056–75.
- EMI Guidelines - Appendix 21 Hepatitis B virus: epidemiology and transmission risks (updated May 2016)
- Raimondi S, Maisonneuve P, Bruno S et al. Is response to antiviral treatment influenced by hepatitis B virus genotype? J Hepatol. 2010; 52:441–449.
- Dutta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virology J. 2008;5:156.
- Yadav K, Biswas D, Baruah P, Borkakoty B, Mahanta J. Hepatitis B Endemicity in Some Parts of Arunachal Pradesh, Northeast India . Indian J Community Med. [Epub ahead of print] [cited 2018 Mar 23]. Available from: http://www.ijcm.org.in/preprintarticle.asp?id=173502.
- Singh H, Aggarwal R, Singh RL, Naik SR, Naik S. Frequency of infection by hepatitis B virus and its surface mutants in a northern Indian population. Ind J Gastroenterol. 2003;22 (4):132-137.
- Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, Datta S, Banerji S, Manna B, Chowdhury SR, Bhattacharya SK, Mazumder DG. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants J Gastroenterol Hepatol. 2005 Nov; 20:1712-20.
- Kurien T, Thyagarajan SP, Jeyaseelan L, et al. Hepatitis B Infection in Tamil Nadu, India. Ind J Med Res. 2005;121(5):670-675.
- Sodhi JS, Raja W, Zargar SA, Javid G, Aejaz S, Khan MA, Showkat A, Parveen S, Jan, A, Nisar S, Yattoo GN, Shah A. Screening for Occult and Overt Hepatitis B Virus Infection in Patients of Cancer before Receiving Chemotherapy: Looking Beyond HBsAg Testing. Int.J. Adv. Res. 2015; 3(1):458-465.
- Wani MI, Rashid A, Tanvir M, Ajaz S. Prevalence of Hepatitis B in Kargil, Ladakh; Community Based study from a Rural area of Jammu and Kashmir. Ann. Int. Med. Dent Res. 2015; 3(5).
- Chalana H, Kundal T, Malhari AS. Changing Trends in Drug Abuse Patterns and Seroprevalence of HIV, Hepatitis B Surface Antigen, and Hepatitis C in Substance Abusers Admitted to A Tertiary Hospital in Amritsar, India. Int J High Risk Behav Addict. 2017.
- Thacker SB. Field Epidemi-ology. Edited by: Gregg MB. 2002, New York: Oxford University Press, 26-50.
- Rubin E. Acute and chronic viral hepatitis. Federation Proceedings 1979; 38: 2665-73.
- Bhatta CP, Thapa B, Rana BB. Seroprevalence of Hepatitis B in Kathmandu Medical College Teaching Hospital. Kathmandu UnivMed J(KUMJ). 2003;1:113-6.
- Quadri SA, Dadapeer HJ, Arifulla KM, Khan N. Prevalence of Hepatitis B Surface Antigen in hospital based population in Bijapur, Karnataka. Al Ameen J Med Scie. 2013; 6(2):180-182.
- Hatkar S, Baviskar J, Kotgire S. Sero-Prevalence of Hepatitis ‘B’ Virus Infection: A Teaching Hospital Based Study. Int.J.Curr.Microbiol.App.Sci. 2016; 5(12): 524-52.
- Parimala TV. A Retrospective Study on Seroprevalence of Hepatitis B Surface Antigen among Patients in a Tertiary Care Hospital, South India. Int. J. Curr. Microbiol. App.Sci. 2016; 5 (11):329-333.
- Bhatta B, Thapa R, Pant P, Pandeya DR. A Retrospective Hospital Based Study In Kathmandu to Assess the Seroprevalence of Hepatitis B Virus. JMMIHS 2016; 2:3-6
- Isa I, Aminu M, Abdullahi SA, Sani MA and Akafyi DE. Seroprevelance of hepatitis b virus in a tertiary institution in North Western Nigeria. Afr. J. Microbiol. Res. 2015; 9(3): 171-179.
- Makroo RN, Hegde V, Chowdhry M, Bhatia A, Rosamma NL. Seroprevalence of infectious markers & their trends in blood donars in a hospital based blood bank in north India. Indian J. Med. Res. 2015; 142: 317-322.
- Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007; 44:663-74.
- Batham A, Gupta MA, Rastogi P, Garg S, Sreenivas V, Puliyel JM. Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis. Indian J Pediatr. 2009;76:1247–1257.
- Prevention of Hepatitis B in India – An Overview. New Delhi: World Health Organization South-East Asia Regional Office; 2002
- Puri P. Tackling the Hepatitis B Disease Burden in India. J clin exp hepatol. 2014;4:312–319.
- Balamurugan, Gopal R, Saleem M, Kaviraj M, Shivekar SA, Mangaiyarkarasi T. Prevalence of Hepatitis B Surface Antigen among Patients Attending a Rural Teaching Hospital at Puducherry. Indian J Microbiol Res. 2016; 3 :74-6.
- Sood S and Malvankar S. Seroprevalence of Hepatitis B Surface Antigen, Antibodies to Hepatitis C virus and Human immunodeficiency virus in a Hospital Based Population in Jaipur, Rajasthan, Indian J Community Med. 2010; 35(1):165-169.
- Singh K, Bhat S, Shastry S. Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka. India J Infect Dev Ctries. 2009; 3(5):376-379.
- Ahmad B, Grover R, Ratho RK, Mahajan RC. Prevalence of hepatitis B virus infection in Chandigarh over a six year period. Trop Gastroenterol. 2001;22:18-9.
- Dutta S, Shivanand PG, Chatterjee A. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal. Indian J Public Health. 1994; 38: 108-12.
- Tessema B, Yismaw G, Kassu A et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010; 10(111).
- Ayele AG, Gebre-Selassie S. Prevalence and Risk Factors of Hepatitis B and Hepatitis C Virus Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa, Ethiopia ISRN ISRN Trop Med. 2013; Article ID 563821, http://dx.doi.org/10.1155/2013/563821.
- Pennap GR, Yakubu A, Oyige O, Forbi J. Prevelance of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. Afr. J. Microbiol. Res 2010; 4(4) :274-278.
- Okonko IO, Okerentugba PO and Akinpelu AO. Prevelance of HBsAg among attendees of ARFH centre in Ibandan, Southwestern Nigeria. Am- Eurasian J Sci Res. 2012; 7(3):100-105.
- Seoung-Ae L, Hong K, You-Sub W, Seung-Hyeok S, YiRang N, Han-Bo S, Kyung-Soo I, Bum-Joon K. Male-specific hepatitis B virus large surfaceprotein variant W4P potentiates tumorigenicity and induces gender disparity Mol. Cancer Biol. 2015; 14:23.
- Giri PA, Deshpande JD, Phalke DB and Karle LB. Seroprevalence of Transfusion Transmissible infections among voluntary blood donars at a tertiary care teaching hospital in rural area of India. J Family Med Prim Care. 2012; 1:1.
- Naik TB, Sathish JV, Wadekar MD. Seroprevalence of Hepatitis B Surface Antigen (HBsAg) among Patients Attending a Tertiary Care Hospital at Chamarajanagar, Karnataka, India. Int. J. Curr. Microbiol.App.Sci. 2018; 7(01): 1279-1284.
- Beltagy EL, Al Balawi KE, Almuneef IAM, Memish ZA. Prervelance of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, North Western Saudi Arabia. Int. J. Infect. Dis. 2008; 12: 495-499.
- Thomas K, Thyagarajan SP, Jeyaseelan L, Varghese JC, Krishnamurthy P, Lakshmibai, et al. Community prevalence of sexually transmitted disease and human immunodeficiency virus infection in Tamilnadu, India:A probability proportional to size cluster survey. Nat Med J India. 2002;15:135-40.
- Tankhiwale SS, Khadase RK, Jalgoankar SV. Seroprevalence of anti-HCV and hepatitis B surface antigen in HIV infected patients. Ind J Med Microbial. 2003;21:268-70.
- Rogers MC, Kumarasamy N, Chaguturu SK, Flanigan TP, Mayer KH, Balakrishnan P, et al. Hepatitis B, Hepatitis C and HIV coinfection in Chennai, India. XI CROI, San Fransico, February 2004, Abstract No. 796
- Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, et al. Prevalence of HCV and HBV infection among HIV seropositive intravenous drug users and their non-injecting wives in Manipur, India. Ind J Med Res. 2000; 111:37-9.
Corresponding Author
Dr Shashi S Sharma
Prof, PI and Nodal Officer
VRDL Dept. of Microbiology, GMC Jammu, India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v6i6.106
